Disruption of Pharmacotherapy During the Transition from Adolescence to Early Adulthood in Patients with Attention-Deficit/Hyperactivity Disorder: A Claims Database Analysis Across the USA.

Sepehr FarahbakhshianRajeev AyyagariDaniel S BarczakSimerpal K GillWenxi TangThomas KulalertMadeline JenkinsWilliam Spalding

Published in: CNS drugs (2021)

Patients rarely reinitiated treatment after pharmacotherapy was disrupted or discontinued, emphasizing the need for increased focus on the management of ADHD as patients transition from adolescence to adulthood.

Keyphrases

attention deficit hyperactivity disorder
end stage renal disease
depressive symptoms
autism spectrum disorder
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
working memory
smoking cessation
patient reported
combination therapy
adverse drug